fbpx
Facebook-f Twitter Youtube Linkedin
LIBRARY
HEADlines
ISSUES

A patient in New Zealand became the first person to receive a gene-editing serum to permanently lower levels of ‘bad’ LDL cholesterol, a major cause of heart disease worldwide. The procedure involved injecting an improved version of the gene-editing tool, CRISPR, to turn off a ‘bad’ gene by replacing a single letter in the liver DNA.

Join our mailing list

Stay updated on all the latest news and events

SIGN UP NOW

20 Upper Circular Road
The Riverwalk, #02-21
Singapore 058416
+65 6672 6160
info@headfoundation.org

Facebook Twitter Youtube Linkedin

Let’s connect.

Do you have any questions about our projects or our site in general? Do you have any comments or ideas you would like to share with us?

Please feel free to call us, email us or simply send us a message from here.

Copyright © 2021 The HEAD Foundation. All Rights Reserved.

Mr Ho Swee Huat

Mr Ho Swee Huat is the Founder and Managing Director of Abacus Assets Advisors Pte Ltd. Before starting the company, he had an established career in the banking industry, with 20 years of experience in Singapore, Hong Kong and New York.

He was an Independent Director and Chairman of the Audit Committee of CapitaCommercial Trust Management LTD from 2004 to 2013.

He is the current Chairman of Autism Association (Singapore) which he co-founded with a group of parents in 1992. He is also Vice-Chairman of Eden School, a special school for children with autism.

Mr Ho holds a Master’s degree from the London School of Economics and Political Science, and a Liberal Arts degree in Economics from Hamilton College, USA.

He has been a member of the Board of the Foundation since its incorporation.